rapacuronium (Raplon)
Jump to navigation
Jump to search
Introduction
Withdrawn from US market in 2001 due to cases of severe bronchospasm.
Pharmacokinetics
very rapid onset of action
More general terms
References
- ↑ Kaiser Permanente Northern California Regional Drug Formulary, 2000